Otsuka (OTCMKTS:OTSKY) Posts Earnings Results, Beats Estimates By $0.05 EPS

Otsuka (OTCMKTS:OTSKY) announced its quarterly earnings results on Friday. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.05, Zacks reports. Otsuka had a return on equity of 12.86% and a net margin of 15.50%.

Otsuka Stock Down 2.4%

Shares of OTCMKTS OTSKY traded down $0.95 during mid-day trading on Friday, hitting $37.93. 27,515 shares of the stock traded hands, compared to its average volume of 41,434. The company has a market cap of $40.74 billion, a price-to-earnings ratio of 15.23, a PEG ratio of 2.76 and a beta of 0.09. The stock has a fifty day moving average price of $37.38 and a 200-day moving average price of $34.79. Otsuka has a 52 week low of $26.11 and a 52 week high of $40.92. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.65 and a current ratio of 2.21.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Otsuka from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 9th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

About Otsuka

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that manages a group of businesses focused primarily on pharmaceuticals, nutraceuticals, and consumer health products. Through its subsidiaries, the company researches, develops, manufactures, and markets prescription medicines, over-the-counter products, functional foods, and beverages.

Its pharmaceutical operations address areas including psychiatry, oncology, cardiovascular and renal diseases, and several other specialty conditions.